PuSH - Publication Server of Helmholtz Zentrum München

86 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Jacobsen, L.M.* et al.: Heterogeneity of DKA incidence and age-specific clinical characteristics in children diagnosed with type 1 diabetes in the TEDDY Study. Diabetes Care 45, 624-633 (2022)
2.
Karl, F. ; Winkler, C. ; Ziegler, A.-G. ; Laxy, M. & Achenbach, P.: Costs of public health screening of children for presymptomatic type 1 diabetes in Bavaria, Germany. Diabetes Care 45, 837-844 (2022)
3.
Schlögl, H. & Stumvoll, M.*: The brains behind SGLT2 inhibition. Diabetes Care 45, 273-275 (2022)
4.
Tobi, E.W.* et al.: Maternal glycemic dysregulation during pregnancy and neonatal blood DNA methylation: Meta-analyses of epigenome-wide association studies. Diabetes Care 45, 614-623 (2022)
5.
Ahuja, V.* et al.: Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults: A meta-analysis. Diabetes Care 44, 1062-1069 (2021)
6.
Anand, V.* et al.: Islet autoimmunity and HLA markers of presymptomatic and clinical type 1 diabetes: Joint analyses of prospective cohort studies in Finland, Germany, Sweden, and the U.S. Diabetes Care 44, 2269-2276 (2021)
7.
Bizzotto, R.* et al.: Processes underlying glycemic deterioration in type 2 diabetes: An IMI DIRECT Study. Diabetes Care 44, 511-518 (2021)
8.
Blonde, L.* et al.: Durable effects of iGlarLixi up to 52 weeks in type 2 diabetes: The LixiLan-G Extension Study. Diabetes Care 44, 774-780 (2021)
9.
Bonifacio, E. et al.: An age-related exponential decline in the risk of multiple islet autoantibody seroconversion during childhood. Diabetes Care 44, 2260-2268 (2021)
10.
Canouil, M.* et al.: Epigenome-wide association study reveals methylation loci associated with offspring gestational diabetes mellitus exposure and maternal methylome. Diabetes Care 44, 1992-1999 (2021)
11.
Kullmann, S. et al.: Empagliflozin improves insulin sensitivity of the hypothalamus in humans with prediabetes: A randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes Care 45, 398-406 (2021)
12.
Neuwahl, S.J.* et al.: Patient health utility equations for a type 2 diabetes model. Diabetes Care 44, 381-389 (2021)
13.
Ng, K.* et al.: Islet autoantibody type-specific titer thresholds improve stratification of risk of progression to type 1 diabetes in children. Diabetes Care 45, 160-168 (2021)
14.
Pedron, S. ; Kurz, C.F. ; Schwettmann, L. & Laxy, M.: The effect of BMI and type 2 diabetes on socioeconomic status: A two-sample multivariable mendelian randomization study. Diabetes Care 44, 850-852 (2021)
15.
Shao, H.* et al.: Trends in total and out-of-pocket payments for noninsulin glucose-lowering drugs among U.S. adults with large-employer private health insurance from 2005 to 2018. Diabetes Care 44, 925-934 (2021)
16.
Shao, H. et al.: Trends in total and out-of-pocket payments for insulin among privately insured U.S. adults with diabetes from 2005 to 2018. Diabetes Care 44, e1-e3 (2021)
17.
Sujana, C. et al.: Natriuretic peptides and risk of type 2 diabetes: Results from the biomarkers for cardiovascular risk assessment in Europe (BiomarCaRE) consortium. Diabetes Care 44, 2527-2535 (2021)
18.
Addala, A.* et al.: A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: A transatlantic comparison. Diabetes Care 44, 133-140 (2020)
19.
Garvey, W.T.* et al.: Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial. Diabetes Care 43, 1085-1093 (2020)
20.
Kahl, S.* et al.: Empagliflozin effectively lowers liver fat content in well-controlled Type 2 Diabetes: A randomized, double-blind, phase 4, placebo-controlled trial. Diabetes Care 43, 298-305 (2020)